NCT04183842 (LACIME) is a NA clinical trial of LACIME Anti-hangover in Headache, sponsored by Incara Lab.

Who is sponsoring NCT04183842?

NCT04183842 is sponsored by Incara Lab.

What drugs are being tested in NCT04183842?

Interventions in NCT04183842: LACIME Anti-hangover, Placebo.

What condition does NCT04183842 study?

NCT04183842 studies Headache, Nausea, Dizziness, Sleepiness, Anxiety, Thirst.

Is NCT04183842 still recruiting?

NCT04183842 is currently completed. Last updated 3 December 2019.

Last reviewed 2019-12-03 · How we verify

NCT04183842: LACIME

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of a Fixed Combination of Herbal Extracts to Prevent Symptoms Alcohol-induced Hangovers

Completed NA Last updated 3 December 2019

What this trial tests

NA trial testing LACIME Anti-hangover in Headache in 40 participants. Completed in 7 September 2019.

Timeline

4 July 2019

Primary endpoint
26 August 2019

7 September 2019

Quick facts

Lead sponsor	Incara Lab
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	quadruple
Primary purpose	prevention
Enrollment	40
Start date	4 July 2019
Primary completion	26 August 2019
Estimated completion	7 September 2019
Sites	1 location across Armenia

Drugs / interventions tested

LACIME Anti-hangover
Placebo

Conditions studied

Headache — all drugs for Headache →
Nausea — all drugs for Nausea →
Dizziness — all drugs for Dizziness →
Sleepiness — all drugs for Sleepiness →

Sponsor

Incara Lab

Who can join

Adults 20 to 30, male only, with Headache or Nausea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of the study is to test whether the tested Product LACIME Anti-hangover is effective in preventing the signs and symptoms of alcohol-induced hangover (such as headache, impaired memory, depression, anxiety, weakness, trouble sleeping and concentrating, nausea, dizziness, sleepiness, thirsty, dry mouth, sweating, sensitivity to light and sounds, vision problems) in healthy subjects.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Headache

Currently open trials in the same condition.

NCT07487649 — Treatment Response in Patients With Medication-Overuse Headache · recruiting
NCT07097792 — Concussion Recovery and Support Program · NA · recruiting
NCT06225817 — Placebo Impacts Sleep and Pain Modulation in Chronic Pain · NA · recruiting
NCT06310200 — Sphenopalatine Ganglion Block and Cold Induced Headaches · Phase 1 · active not recruiting
NCT07404956 — THE EFFECT OF SURGICAL MASK AND N95 MASK USE ON SURGICAL SMOKE IN OPERATING ROOM NURSES · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04183842 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Incara Lab
Last refreshed: 3 December 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04183842.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing